Syndax Pharmaceuticals, Inc. (SNDX): Price and Financial Metrics

Syndax Pharmaceuticals, Inc. (SNDX): $21.32

-0.62 (-2.83%)

POWR Rating

Component Grades














  • Value is the dimension where SNDX ranks best; there it ranks ahead of 68.74% of US stocks.
  • The strongest trend for SNDX is in Quality, which has been heading up over the past 26 weeks.
  • SNDX's current lowest rank is in the Momentum metric (where it is better than 4.71% of US stocks).

SNDX Stock Summary

  • The ratio of debt to operating expenses for SYNDAX PHARMACEUTICALS INC is higher than it is for about only 5.1% of US stocks.
  • With a year-over-year growth in debt of -94.19%, SYNDAX PHARMACEUTICALS INC's debt growth rate surpasses just 1.3% of about US stocks.
  • As for revenue growth, note that SNDX's revenue has grown 836.77% over the past 12 months; that beats the revenue growth of 98.77% of US companies in our set.
  • Stocks that are quantitatively similar to SNDX, based on their financial statements, market capitalization, and price volatility, are RXDX, PSTX, IDYA, ALPN, and BOLT.
  • SNDX's SEC filings can be seen here. And to visit SYNDAX PHARMACEUTICALS INC's official web site, go to

SNDX Valuation Summary

  • SNDX's price/sales ratio is 12.4; this is 148% higher than that of the median Healthcare stock.
  • Over the past 85 months, SNDX's price/sales ratio has gone down 320.3.

Below are key valuation metrics over time for SNDX.

Stock Date P/S P/B P/E EV/EBIT
SNDX 2023-02-17 12.4 4.7 -113.0 -138.6
SNDX 2023-02-16 12.2 4.6 -110.5 -135.4
SNDX 2023-02-15 12.4 4.6 -112.2 -137.7
SNDX 2023-02-14 12.5 4.7 -113.4 -139.1
SNDX 2023-02-13 12.3 4.6 -111.3 -136.5
SNDX 2023-02-10 12.1 4.5 -109.8 -134.5

SNDX Growth Metrics

    The year over year revenue growth rate now stands at 9090.63%.
  • Its 3 year price growth rate is now at 91.27%.
  • Its 2 year revenue growth rate is now at 9090.63%.
SNDX's revenue has moved up $125,060,000 over the prior 15 months.

The table below shows SNDX's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 126.576 -10.072 -13.946
2022-06-30 138.951 -6.472 0.818
2022-03-31 139.33 9.789 15.48
2021-12-31 139.709 29.131 24.926
2021-09-30 13.512 -87.209 -91.695
2021-06-30 1.516 -80.562 -91.493

SNDX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • SNDX has a Quality Grade of D, ranking ahead of 17.57% of graded US stocks.
  • SNDX's asset turnover comes in at 0.006 -- ranking 405th of 682 Pharmaceutical Products stocks.
  • SYRS, LFVN, and ICPT are the stocks whose asset turnover ratios are most correlated with SNDX.

The table below shows SNDX's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.006 1 -0.517
2021-03-31 0.006 1 -0.517
2020-12-31 0.008 1 -0.570
2020-09-30 0.011 1 -0.727
2020-06-30 0.014 1 -0.906
2020-03-31 0.018 1 -1.474

SNDX Price Target

For more insight on analysts targets of SNDX, see our SNDX price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $27.67 Average Broker Recommendation 1.36 (Strong Buy)

SNDX Stock Price Chart Interactive Chart >

Price chart for SNDX

SNDX Price/Volume Stats

Current price $21.32 52-week high $29.86
Prev. close $21.94 52-week low $13.27
Day low $21.25 Volume 528,000
Day high $22.46 Avg. volume 766,507
50-day MA $25.02 Dividend yield N/A
200-day MA $23.15 Market Cap 1.46B

Syndax Pharmaceuticals, Inc. (SNDX) Company Bio

Syndax Pharmaceuticals, Inc., a late-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics in oncology. The company was founded in 2005 and is based in Waltham, Massachusetts.

SNDX Latest News Stream

Event/Time News Detail
Loading, please wait...

SNDX Latest Social Stream

Loading social stream, please wait...

View Full SNDX Social Stream

Latest SNDX News From Around the Web

Below are the latest news stories about SYNDAX PHARMACEUTICALS INC that investors may wish to consider to help them evaluate SNDX as an investment opportunity.

Syndax Pharmaceuticals (SNDX) Outpaces Stock Market Gains: What You Should Know

Syndax Pharmaceuticals (SNDX) closed the most recent trading day at $21.94, moving +1.72% from the previous trading session.

Yahoo | March 27, 2023

Syndax Pharmaceuticals (SNDX) Stock Sinks As Market Gains: What You Should Know

In the latest trading session, Syndax Pharmaceuticals (SNDX) closed at $23.07, marking a -0.26% move from the previous day.

Yahoo | March 21, 2023

Syndax Pharmaceuticals (SNDX) Dips More Than Broader Markets: What You Should Know

Syndax Pharmaceuticals (SNDX) closed the most recent trading day at $22.30, moving -1.24% from the previous trading session.

Yahoo | March 15, 2023

Syndax Pharmaceuticals Announces Two Publications in Nature of Data from the Phase 1 Portion of AUGMENT-101 in Acute Leukemia Patients

Syndax Pharmaceuticals, Inc. (Nasdaq: SNDX) today announced that data from the Phase 1 portion of the ongoing Phase 1/2 AUGMENT-101 trial of revumenib in patients with nucleophosmin mutant (mNPM1) and KMT2A-rearranged (KMT2Ar) relapsed/refractory (R/R) acute leukemia and an analysis describing MEN1 mutations observed in the study have been published in the journal Nature. Revumenib is the Company's highly selective, oral menin inhibitor.

Yahoo | March 15, 2023

Syndax Pharmaceuticals (SNDX) Gains But Lags Market: What You Should Know

Syndax Pharmaceuticals (SNDX) closed the most recent trading day at $22.58, moving +0.71% from the previous trading session.

Yahoo | March 14, 2023

Read More 'SNDX' Stories Here

SNDX Price Returns

1-mo -12.87%
3-mo -13.89%
6-mo -11.28%
1-year 16.82%
3-year 120.93%
5-year 49.82%
YTD -16.23%
2022 16.26%
2021 -1.57%
2020 153.30%
2019 97.30%
2018 -49.20%

Continue Researching SNDX

Here are a few links from around the web to help you further your research on Syndax Pharmaceuticals Inc's stock as an investment opportunity:

Syndax Pharmaceuticals Inc (SNDX) Stock Price | Nasdaq
Syndax Pharmaceuticals Inc (SNDX) Stock Quote, History and News - Yahoo Finance
Syndax Pharmaceuticals Inc (SNDX) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8902 seconds.